LGC Overview
- Founded
- 1842

- Status
- Private
- Employees
- 4,000

- Latest Deal Type
- Debt
- Financing Rounds
- 13
- Investments
- 28
LGC General Information
Description
Provider of scientific testing, specialist analytical and diagnostic laboratory services. The company offers specialty genomic analysis tools, measurement tools and supply chain assurance to customers across clinical diagnostics, pharmaceutical, research & government, food and other applied markets.
Contact Information
- Queens Road
- Teddington TW11 0LY
- England, United Kingdom
LGC Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore LGC‘s full profile, request access.
Request a free trialLGC Comparisons
Industry
00000000
00000 00
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialLGC Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Eurofins Scientific | Corporation | Luxembourg, Luxembourg | 00000 | 00000 | 000000000 | 00000 |
00000 00000000 | Private Equity-Backed | Nashville, TN | 00000 | 000000000 | 00000 |
LGC Patents
LGC Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2017287855-A1 | Method for isolating nucleic acids with bivalent cations and elution with a cation chelating agent | Abandoned | 30-Jun-2016 | 00000000000 | |
US-20190233810-A1 | Method for isolating nucleic acids with bivalent cations and elution with a cation chelating agent | Abandoned | 30-Jun-2016 | 00000000000 | 0 |
EP-3478837-A1 | Method for isolating nucleic acids with bivalent cations and elution with a cation chelating agent | Withdrawn | 30-Jun-2016 | 00000000000 | |
GB-2551801-A | Methods | Pending | 30-Jun-2016 | 00000000000 | 0 |
JP-2019524084-A | Nucleic acid isolation method using divalent cation and elution method using cation chelating agent | Pending | 30-Jun-2016 | C12N15/1013 |
LGC Executive Team (25)
LGC Board Members (16)
Name | Representing | Role | Since |
---|---|---|---|
00000 0000000 | LGC | Board Member & Chief Scientific Officer | 000 0000 |
0000ç000 00 00000 | Astorg (Paris) | Board Member | 000 0000 |
00000 00000 | Astorg (Paris) | Board Member | 000 0000 |
0000 000000 | Self | Board Member & Chair of Audit Committee | 000 0000 |
0000000 000000 | Cinven | Board Member | 000 0000 |
LGC Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialLGC Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore LGC‘s full profile, request access.
Request a free trialLGC Investments (28)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000 0000000 | 01-Apr-2022 | 0000000000 | Biotechnology | 0000 0000 | |
0000000 00000 | 03-Mar-2021 | 0000000000 | Other Commercial Products | 000 00000 | |
0000000000 00 | 01-Feb-2021 | 0000000000 | Drug Discovery | 0000 0'00 | |
00000000 000 | 21-Dec-2020 | 0000000000 | Business/Productivity Software | 000 00000 | |
The Native Antigen Company | 09-Jul-2020 | Buyout/LBO | 000.00 | Biotechnology | 0000000 0 |
LGC Subsidiaries (18)
Company Name | Industry | Location | Founded |
---|---|---|---|
Rapid Genomics | Biotechnology | Gainesville, FL | 2011 |
000 000000 0000000 | Biotechnology | Oxford, United Kingdom | 0000 |
00000000 000 | Business/Productivity Software | Dublin, Ireland | 0000 |
0000000 0000000000 | Biotechnology | Alexandria, MN | 0000 |
0000000000 0000000 | Drug Discovery | Ballina, Ireland | 0000 |